<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Latest Press Release: AGTC Vision Testing Program for Patients Enrolled in Its Ongoing Phase 1/2 Clinical Trials

We recognize the incredible commitment patients make when they enroll in our trials and our goal is to match that commitment and support them in any way possible. Our highest priority is patients and their safety. During the COVID-19 crisis, patients may be less inclined or find it harder to receive in-person follow up appointments, an important aspect of assessing the safety and efficacy of the therapy. By using a creative patient focused approach to testing via our mobile vision testing program, we “take the test to the patient” to support their needs during this extremely difficult time.

- Sue Washer, President and CEO of AGTC

IMG_8348 copy-2


Solutions designed to fit your needs.

What risks are you facing with your studies and trials? We help BioPharma Sponsors, CROs, and Study

Sites to mitigate risk and ensure continuity of care and follow-up assessments without having to over-invest.

Learn More


2020 web icons 100x100-15-1 
Help with High Risk Groups

Do you have a COVID-19 related logistical or safety issue for your population? 

2020 web icons 150x150-08
Study Rescue

Do you need to keep critical checkpoints on track by delivering exams in an expedited fashion?

2020 web icons 100x100-01
Comprehensive Exams

Do you need an easy and safe way to help patients access routine eye exams?

2020 web icons 100x100-16
Better Impact & Outreach

Do you want to access patients in a larger geographical region than participating facilities allows?